Cargando…
Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis
The 27-year-old pregnant woman has been overweight since her childhood. Endocrinological assessments did not confirm hormonal disease. Her pregnancy was without complication. A signs of intrauterine distress were observed and elective caesarean section was performed under heparin protection because...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603639/ https://www.ncbi.nlm.nih.gov/pubmed/23533867 http://dx.doi.org/10.1155/2013/689549 |
_version_ | 1782263705045565440 |
---|---|
author | Horváth, Boldizsar Skrapits, Judit Bódis, József |
author_facet | Horváth, Boldizsar Skrapits, Judit Bódis, József |
author_sort | Horváth, Boldizsar |
collection | PubMed |
description | The 27-year-old pregnant woman has been overweight since her childhood. Endocrinological assessments did not confirm hormonal disease. Her pregnancy was without complication. A signs of intrauterine distress were observed and elective caesarean section was performed under heparin protection because of anatomy unsuitable for delivery per vias naturals. The mother's bodyweight was 184 kg. By monitoring the change in fX activity LMWH treatment (Enoxaparin) initiated with a dose of 120 mg twice daily and then the dose was gradually elevated to 200 mg twice daily thereby achieving the lower range of the desired therapeutic effect. Apart from mild disorder of wound healing, the recovery was free of complication. The patient suffered from thrombophilia (extremely overweight, pregnant, thrombophlebitis under the knee, surgery, and postoperative immobilization). In case of quite extreme bodyweight there is no dosage recommendation or clinical practice for LMWH. Because of the extreme overweight and the therapeutic dose titration test of heparin, monitoring of fX activity by measurement of inhibition, dosage of heparin other than the recommended (abdominal wall instead of upper arm SC), and the very fluctuating heparin dosage which is well correlating with clinical practice, it is reasonably expected that this case will take interest. |
format | Online Article Text |
id | pubmed-3603639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36036392013-03-26 Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis Horváth, Boldizsar Skrapits, Judit Bódis, József Case Rep Obstet Gynecol Case Report The 27-year-old pregnant woman has been overweight since her childhood. Endocrinological assessments did not confirm hormonal disease. Her pregnancy was without complication. A signs of intrauterine distress were observed and elective caesarean section was performed under heparin protection because of anatomy unsuitable for delivery per vias naturals. The mother's bodyweight was 184 kg. By monitoring the change in fX activity LMWH treatment (Enoxaparin) initiated with a dose of 120 mg twice daily and then the dose was gradually elevated to 200 mg twice daily thereby achieving the lower range of the desired therapeutic effect. Apart from mild disorder of wound healing, the recovery was free of complication. The patient suffered from thrombophilia (extremely overweight, pregnant, thrombophlebitis under the knee, surgery, and postoperative immobilization). In case of quite extreme bodyweight there is no dosage recommendation or clinical practice for LMWH. Because of the extreme overweight and the therapeutic dose titration test of heparin, monitoring of fX activity by measurement of inhibition, dosage of heparin other than the recommended (abdominal wall instead of upper arm SC), and the very fluctuating heparin dosage which is well correlating with clinical practice, it is reasonably expected that this case will take interest. Hindawi Publishing Corporation 2013 2013-03-04 /pmc/articles/PMC3603639/ /pubmed/23533867 http://dx.doi.org/10.1155/2013/689549 Text en Copyright © 2013 Boldizsar Horváth et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Horváth, Boldizsar Skrapits, Judit Bódis, József Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title | Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title_full | Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title_fullStr | Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title_full_unstemmed | Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title_short | Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis |
title_sort | obstetrical management of an extremely overweight pregnant woman (184 kg bw) with special attention on thromboprophylaxis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603639/ https://www.ncbi.nlm.nih.gov/pubmed/23533867 http://dx.doi.org/10.1155/2013/689549 |
work_keys_str_mv | AT horvathboldizsar obstetricalmanagementofanextremelyoverweightpregnantwoman184kgbwwithspecialattentiononthromboprophylaxis AT skrapitsjudit obstetricalmanagementofanextremelyoverweightpregnantwoman184kgbwwithspecialattentiononthromboprophylaxis AT bodisjozsef obstetricalmanagementofanextremelyoverweightpregnantwoman184kgbwwithspecialattentiononthromboprophylaxis |